Background Myeloma causes profound immunodeficiency and recurrent, serious infections.
Around 5500 new cases of myeloma are diagnosed per year in the UK, and a quarter of …

The combination of docetaxel, cisplatin, and 5‐fluorouracil (DCF) as preoperative treatment
for esophageal squamous cell carcinoma (ESCC) has not been investigated. We carried out …

Purpose To validate a prognostic score predicting major complications in patients with solid
tumors and seemingly stable episodes of febrile neutropenia (FN). The definition of clinical …

Importance Determining innovative approaches that better align health needs to the
appropriate setting of care remains a key priority for the transformation of US health care; …

Hematologic and oncologic patients with chemo-or immunotherapy-related
immunosuppression are at substantial risk for bacterial infections and Pneumocystis jirovecii …

Infection remains one of the most prominent complications after cytotoxic treatment for
cancer. The connection between neutropenia and both infections and fever has long been …

In this report, a panel of European myeloma experts discuss the role of pomalidomide in the
treatment of relapsed and refractory multiple myeloma (RRMM). Based on the available …

Sepsis is a major cause of mortality during the neutropenic phase after intensive cytotoxic
therapies for malignancies. Improved management of sepsis during neutropenia may …

Little information is currently available regarding bloodstream infection (BSI) in patients with
solid tumors who, for a variety of reasons, are particularly predisposed to develop this …

British HIV Association guidelines for HIV‐associated malignancies 2014 Page 1 DOI:
10.1111/hiv.12136 © 2014 British HIV Association HIV Medicine (2014), 15 (Suppl. 2), 1Ȃ92 …